Inventor · disambiguated record
Divyakant Desai
Also filed as: DESAI DIVYAKANT · DESAI DIVYAKANT S · DESAI DIVYAKANT SHANTILAL
14 granted patents·12 pending applications·179 citations·filing 1995–2023
92Inventor score
Top patents by PatentIndex Score
26 records- 0193US7951400B2Coated tablet formulation and methodBRISTOL MYERS SQUIBB CO·Filed 2005·Granted May 31, 2011·20 cites·10 claims
- 0292US7507768B2Antidiabetic formulation and methodBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Mar 24, 2009·18 cites·13 claims
- 0389US8518421B2Flashmelt oral dosage formulationKOTHARI SANJEEV H·Filed 2011·Granted Aug 27, 2013·24 cites·18 claims
- 0480US8535715B2Bilayer tablet formulationsABEBE ADMASSU·Filed 2010·Granted Sep 17, 2013·7 cites·38 claims
- 0579US9050258B2Bilayer tablet formulationsASTRAZENECA AB·Filed 2013·Granted Jun 9, 2015·3 cites·12 claims
- 0679US5994348APharmaceutical compositions containing irbesartanSANOFI SA·Filed 1998·Granted Nov 30, 1999·56 cites·26 claims
- 0778US9616028B2Bilayer tablet formulationsASTRAZENECA AB·Filed 2015·Granted Apr 11, 2017·2 cites·8 claims
- 0877US7183321B2Antidiabetic formulation and methodBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Feb 27, 2007·8 cites·7 claims
- 0975US8628799B2Coated tablet formulation and methodDESAI DIVYAKANT S·Filed 2011·Granted Jan 14, 2014·3 cites·11 claims
- 1074US6627224B2Low dose entecavir formulation and useBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Sep 30, 2003·10 cites·53 claims
- 1163US2010016448A1Flashmelt oral dosage formulationBRISTOL MYERS SQUIBB CO·Filed 2009·Application pending·0 cites
- 1262US9339472B2Coated tablet formulation and methodASTRAZENECA AB·Filed 2014·Granted May 17, 2016·0 cites·20 claims
- 1361US2014255486A1Coated Tablet Formulation and MethodASTRAZENECA AB·Filed 2014·Application pending·0 cites
- 1459US9358207B2Flashmelt oral dosage formulationOTSUKA PHARMA CO LTD·Filed 2013·Granted Jun 7, 2016·0 cites·20 claims
- 1555US2017333353A1Bilayer tablet formulationsASTRAZENECA AB·Filed 2017·Application pending·0 cites
- 1654US2025213548A1Pharmaceutical compositions for improving oral bioavailabilityBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1751US2007275059A1Flashmelt oral dosage formulationKOTHARI SANJEEV·Filed 2004·Application pending·0 cites
- 1845US10973768B2Extended release pharmaceutical formulations of water-soluble active pharmaceutical ingredients and methods for making the sameBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Apr 13, 2021·0 cites·29 claims
- 1945US2002076437A1Flashmelt oral dosage formulationFiled 2001·Application pending·0 cites
- 2044US2024122857A1Pharmaceutical formulations of indoleamine 2, 3-dioxygenase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 2143US2014079778A1Pharmaceutical Formulations Including An Amine CompoundNARANG AJIT·Filed 2012·Application pending·0 cites
- 2242US2013224296A1Drug Formulations Using Water Soluble AntioxidantsNARANG AJIT·Filed 2011·Application pending·0 cites
- 2340US2003190334A1Low dose liquid entecavir formulations and useFiled 2003·Application pending·0 cites
- 2439US2006099254A1Sustained release drug delivery system and methodDESAI DIVYAKANT S·Filed 2005·Application pending·0 cites
- 2536US5801220ARapidly disintegrating thickening compositionSQUIBB & SONS INC·Filed 1995·Granted Sep 1, 1998·28 cites·12 claims
- 2634US2005214373A1Coated tablet formulation and methodDESAI DIVYAKANT S·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →